303 related articles for article (PubMed ID: 35460240)
1. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
Rider LG; Parks CG; Wilkerson J; Schiffenbauer AI; Kwok RK; Noroozi Farhadi P; Nazir S; Ritter R; Sirotich E; Kennedy K; Larche MJ; Levine M; Sattui SE; Liew JW; Harrison CO; Moni TT; Miller AK; Putman M; Hausmann J; Simard JF; Sparks JA; Miller FW;
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI143-SI150. PubMed ID: 35460240
[TBL] [Abstract][Full Text] [Related]
2. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
Sattui SE; Liew JW; Kennedy K; Sirotich E; Putman M; Moni TT; Akpabio A; Alpízar-Rodríguez D; Berenbaum F; Bulina I; Conway R; Singh AD; Duff E; Durrant KL; Gheita TA; Hill CL; Howard RA; Hoyer BF; Hsieh E; El Kibbi L; Kilian A; Kim AH; Liew DFL; Lo C; Miller B; Mingolla S; Nudel M; Palmerlee CA; Singh JA; Singh N; Ugarte-Gil MF; Wallace J; Young KJ; Bhana S; Costello W; Grainger R; Machado PM; Robinson PC; Sufka P; Wallace ZS; Yazdany J; Harrison C; Larché M; Levine M; Foster G; Thabane L; Rider LG; Hausmann JS; Simard JF; Sparks JA
RMD Open; 2021 Sep; 7(3):. PubMed ID: 34493645
[TBL] [Abstract][Full Text] [Related]
3. Association of COVID-19 Vaccinations With Flares of Systemic Rheumatic Disease: A Case-Crossover Study.
Braverman G; Barbhaiya M; Nong M; Bykerk VP; Hupert N; Lewis C; Mandl LA
Arthritis Care Res (Hoboken); 2024 May; 76(5):733-742. PubMed ID: 38163750
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Farisogullari B; Lawson-Tovey S; Hyrich KL; Gossec L; Carmona L; Strangfeld A; Mateus EF; Schäfer M; Rodrigues A; Hachulla E; Gomez-Puerta JA; Mosca M; Durez P; Trefond L; Goulenok T; Cornalba M; Stenova E; Bulina I; Strakova E; Zepa J; Roux N; Brocq O; Veillard E; Raffeiner B; Burmester GR; Mariette X; Machado PM;
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38816065
[TBL] [Abstract][Full Text] [Related]
5. Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination.
Kim JW; Jung JY; Suh CH; Ye YM; Kim HA
J Korean Med Sci; 2023 Aug; 38(32):e247. PubMed ID: 37582497
[TBL] [Abstract][Full Text] [Related]
6. Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
De Stefano L; Balduzzi S; Bogliolo L; D'Onofrio B; di Lernia M; Mauric E; Milanesi A; Brandolino F; Rocca C; Chiricolo S; Manzo A; Montecucco C; Bugatti S
Clin Exp Rheumatol; 2023 Mar; 41(3):667-675. PubMed ID: 36135948
[TBL] [Abstract][Full Text] [Related]
7. The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.
Xie Y; Liu Y; Liu Y
Front Immunol; 2022; 13():919979. PubMed ID: 35860285
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
Fragoulis GE; Bournia VK; Mavrea E; Evangelatos G; Fragiadaki K; Karamanakos A; Kravariti E; Laskari K; Panopoulos S; Pappa M; Mitsikostas DD; Tektonidou MG; Vassilopoulos D; Sfikakis PP
Rheumatol Int; 2022 Jan; 42(1):31-39. PubMed ID: 34739573
[TBL] [Abstract][Full Text] [Related]
9. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
Connolly CM; Ruddy JA; Boyarsky BJ; Barbur I; Werbel WA; Geetha D; Garonzik-Wang JM; Segev DL; Christopher-Stine L; Paik JJ
Arthritis Rheumatol; 2022 Jan; 74(1):28-32. PubMed ID: 34346185
[TBL] [Abstract][Full Text] [Related]
10. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys.
Jagtap K; Naveen R; Day J; Sen P; Vaidya B; Nune A; Nikiphorou E; Tan AL; Agarwal V; Saha S; Shinjo SK; Ziade N; Joshi M; Velikova T; Milchert M; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Dec; 62(12):3838-3848. PubMed ID: 36961331
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study.
Fong W; Woon TH; Chew LC; Low A; Law A; Poh YJ; Yeo SI; Leung YY; Ma M; Santosa A; Kong KO; Xu C; Teng GG; Mak A; Tay SH; Chuah TY; Roslan NE; Angkodjojo S; Phang KF; Sriranganathan M; Tan TC; Cheung P; Lahiri M
Adv Rheumatol; 2023 Aug; 63(1):38. PubMed ID: 37528453
[TBL] [Abstract][Full Text] [Related]
12. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
Ozdede A; Guner S; Ozcifci G; Yurttas B; Toker Dincer Z; Atli Z; Uygunoğlu U; Durmaz E; Uçar D; Uğurlu S; Saip S; Tabak F; Hamuryudan V; Seyahi E
Rheumatol Int; 2022 Jun; 42(6):973-987. PubMed ID: 35376962
[TBL] [Abstract][Full Text] [Related]
13. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
[TBL] [Abstract][Full Text] [Related]
14. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
R N; Sen P; Griger Z; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 Jan; 63(1):127-139. PubMed ID: 37084267
[TBL] [Abstract][Full Text] [Related]
15. Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
Ma M; Santosa A; Fong W; Chew LC; Low AH; Law A; Poh YJ; Yeo SI; Leung YY; Ng VW; Koh JZ; Tay SH; Mak A; Teng GG; Xu C; Tang JG; Kong KO; Angkodjojo S; Goh WR; Chuah TY; Roslan NE; Arkachaisri T; Teh KL; Sriranganathan M; Tan TC; Phang KF; Yap QV; Chan YH; Cheung PP; Lahiri M
J Autoimmun; 2023 Jan; 134():102959. PubMed ID: 36473406
[TBL] [Abstract][Full Text] [Related]
16. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Mok CC; Chan KL; Tse SM
Vaccine; 2022 Sep; 40(41):5959-5964. PubMed ID: 36085256
[TBL] [Abstract][Full Text] [Related]
17. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
He Y; Xue X; Dalbeth N; Terkeltaub R; Chen Y; Yan F; Pang L; Li X; Yuan X; Cheng X; Li C; Sun M
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):131-139. PubMed ID: 37553607
[TBL] [Abstract][Full Text] [Related]
19. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
20. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico.
González-Meléndez A; Báez-Negrón L; Ríos-Rivera R; Franco-O'Connell AS; Nieves-Plaza M; Vilá LM
Lupus; 2023 Apr; 32(4):571-579. PubMed ID: 36639887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
